$25.39
1.255.16%
Last update: Aug 7, 2:00 PM
Sutro Biopharma (STRO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-3.04 | $-4.52 | $-3.70 | $-4.70 |
| Actual | $-2.94 | $-5.29 | $-6.70 | $-1.40 |
| Surprise | +3.29% | -17.0% | -81.1% | +70.2% |
| Revenue | ||||
| Estimate | $7.7M | $8.6M | $8.8M | $15.0M |
| Actual | $14.5M | $11.6M | $9.7M | $63.7M |
| Surprise | +88.1% | +34.9% | +10.1% | +324.1% |
| Metric | Q2 '26E | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.33 | $-2.38 | $-2.01 | $-1.89 |
| Revenue | ||||
| Consensus | $10.7M | $8.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $-2.94 | $-3.04 | 3.29 % |
| Q4 | Mar 23, 2026 | $-5.29 | $-4.52 | -17.0 % |
| Q3 | Nov 6, 2025 | $-6.70 | $-3.70 | -81.1 % |
| Q2 | Aug 7, 2025 | $-1.40 | $-4.70 | 70.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $14.52M | $7.72M | 88.1 % |
| Q4 | Mar 23, 2026 | $11.65M | $8.64M | 34.9 % |
| Q3 | Nov 6, 2025 | $9.69M | $8.81M | 10.1 % |
| Q2 | Aug 7, 2025 | $63.75M | $15.03M | 324.1 % |